$88.00
+1.10 (+1.27%)
Open$88.78
Previous Close$86.90
Day High$88.78
Day Low$81.37
52W High$97.97
52W Low$12.66
Volume—
Avg Volume57.6K
Market Cap276.25M
P/E Ratio—
EPS$-0.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
-85.9% upside
Current
$88.00
$88.00
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.69M | 13.27M | 80.43M |
| Net Income | -7,169,554 | -3,774,332 | 27.17M |
| Profit Margin | -31.6% | -30.0% | 33.8% |
| EBITDA | -8,693,243 | -4,830,709 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | +71.0% | +71.0% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |